Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ten analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $12.3250.
HLN has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft cut Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Morgan Stanley restated an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Haleon in a research report on Tuesday.
View Our Latest Stock Report on HLN
Haleon Trading Up 3.0%
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. Private Trust Co. NA grew its position in shares of Haleon by 13.3% during the second quarter. Private Trust Co. NA now owns 8,794 shares of the company’s stock valued at $91,000 after purchasing an additional 1,032 shares in the last quarter. National Bank of Canada FI raised its stake in shares of Haleon by 6.7% in the third quarter. National Bank of Canada FI now owns 17,385 shares of the company’s stock valued at $156,000 after acquiring an additional 1,099 shares during the period. Cary Street Partners Financial LLC boosted its stake in shares of Haleon by 20.1% during the 2nd quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock worth $69,000 after purchasing an additional 1,113 shares during the period. Cardinal Capital Management grew its holdings in Haleon by 2.4% during the 3rd quarter. Cardinal Capital Management now owns 48,085 shares of the company’s stock valued at $431,000 after purchasing an additional 1,116 shares during the last quarter. Finally, Advisory Services Network LLC grew its holdings in Haleon by 7.1% during the 3rd quarter. Advisory Services Network LLC now owns 17,431 shares of the company’s stock valued at $156,000 after purchasing an additional 1,155 shares during the last quarter. 6.67% of the stock is owned by institutional investors.
About Haleon
Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.
The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.
Recommended Stories
- Five stocks we like better than Haleon
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
